Sichuan Hebang Biotechnology Corporation Limited (SHA: 603077)
China
· Delayed Price · Currency is CNY 1.680
-0.030 (-1.75%)
Sep 6, 2024, 3:00 PM CST
Sichuan Hebang Biotechnology Corporation Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 9,454 | 8,707 | 12,941 | 9,928 | 5,232 | 5,954 | Upgrade
|
| Other Revenue | 127.95 | 117.15 | 97.73 | 59.66 | 29.16 | 14.96 | Upgrade
|
| Revenue | 9,582 | 8,824 | 13,039 | 9,987 | 5,261 | 5,969 | Upgrade
|
| Revenue Growth (YoY) | -0.71% | -32.33% | 30.55% | 89.85% | -11.87% | -0.66% | Upgrade
|
| Cost of Revenue | 7,974 | 6,823 | 7,492 | 5,874 | 4,345 | 4,745 | Upgrade
|
| Gross Profit | 1,608 | 2,001 | 5,547 | 4,113 | 916.12 | 1,224 | Upgrade
|
| Selling, General & Admin | 491.88 | 456.82 | 871.3 | 344.56 | 315.52 | 484.25 | Upgrade
|
| Research & Development | 44.03 | 47.35 | 67.93 | 33.31 | 39.68 | 38.3 | Upgrade
|
| Other Operating Expenses | 72.47 | 60.72 | 110.17 | 89.1 | 43.9 | 45.42 | Upgrade
|
| Operating Expenses | 615.69 | 579.06 | 1,061 | 462.95 | 393.59 | 581.26 | Upgrade
|
| Operating Income | 992.67 | 1,422 | 4,486 | 3,651 | 522.54 | 643.23 | Upgrade
|
| Interest Expense | -34.35 | -24.37 | -51.43 | -77.82 | -82.16 | -57.04 | Upgrade
|
| Interest & Investment Income | 83.48 | 135.57 | 44.52 | 36.31 | 28.04 | 6.91 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.3 | -1.87 | 5.22 | -14.7 | -32.72 | -7.69 | Upgrade
|
| Other Non Operating Income (Expenses) | -10.91 | -10.11 | -1.55 | -14.91 | -9.52 | -4.67 | Upgrade
|
| EBT Excluding Unusual Items | 1,030 | 1,521 | 4,482 | 3,579 | 426.17 | 580.74 | Upgrade
|
| Impairment of Goodwill | - | - | -66.07 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.3 | - | - | - | - | -1.23 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.58 | 0.69 | 36.99 | -1.23 | 6.67 | -2.42 | Upgrade
|
| Other Unusual Items | 22.59 | 14.39 | 25.31 | 0.2 | -417.03 | 6.67 | Upgrade
|
| Pretax Income | 1,052 | 1,536 | 4,479 | 3,578 | 15.81 | 583.75 | Upgrade
|
| Income Tax Expense | 188.84 | 257.27 | 668.32 | 551.88 | 12.9 | 77.14 | Upgrade
|
| Earnings From Continuing Operations | 863.61 | 1,279 | 3,810 | 3,027 | 2.91 | 506.61 | Upgrade
|
| Minority Interest in Earnings | -4.62 | 4.54 | -3.43 | -8.03 | 38.03 | 10.24 | Upgrade
|
| Net Income | 858.98 | 1,283 | 3,807 | 3,018 | 40.94 | 516.85 | Upgrade
|
| Net Income to Common | 858.98 | 1,283 | 3,807 | 3,018 | 40.94 | 516.85 | Upgrade
|
| Net Income Growth | -51.98% | -66.29% | 26.12% | 7272.47% | -92.08% | 42.35% | Upgrade
|
| Shares Outstanding (Basic) | 8,507 | 8,706 | 8,697 | 8,436 | 8,530 | 8,658 | Upgrade
|
| Shares Outstanding (Diluted) | 8,507 | 8,706 | 8,697 | 8,436 | 8,530 | 8,658 | Upgrade
|
| Shares Change (YoY) | -2.16% | 0.10% | 3.10% | -1.10% | -1.48% | -4.62% | Upgrade
|
| EPS (Basic) | 0.10 | 0.15 | 0.44 | 0.36 | 0.00 | 0.06 | Upgrade
|
| EPS (Diluted) | 0.10 | 0.15 | 0.44 | 0.36 | 0.00 | 0.06 | Upgrade
|
| EPS Growth | -50.92% | -66.32% | 22.33% | 7354.17% | -91.96% | 49.25% | Upgrade
|
| Free Cash Flow | -1,159 | -748.4 | 1,708 | 1,462 | 171.76 | -499.62 | Upgrade
|
| Free Cash Flow Per Share | -0.14 | -0.09 | 0.20 | 0.17 | 0.02 | -0.06 | Upgrade
|
| Dividend Per Share | 0.020 | - | 0.045 | 0.015 | - | - | Upgrade
|
| Dividend Growth | -55.56% | - | 200.00% | - | - | - | Upgrade
|
| Gross Margin | 16.79% | 22.67% | 42.54% | 41.19% | 17.41% | 20.51% | Upgrade
|
| Operating Margin | 10.36% | 16.11% | 34.40% | 36.55% | 9.93% | 10.78% | Upgrade
|
| Profit Margin | 8.96% | 14.54% | 29.20% | 30.22% | 0.78% | 8.66% | Upgrade
|
| Free Cash Flow Margin | -12.10% | -8.48% | 13.10% | 14.64% | 3.26% | -8.37% | Upgrade
|
| EBITDA | 1,993 | 2,410 | 5,400 | 4,282 | 1,165 | 1,279 | Upgrade
|
| EBITDA Margin | 20.80% | 27.31% | 41.42% | 42.87% | 22.15% | 21.42% | Upgrade
|
| D&A For EBITDA | 1,000 | 987.99 | 914.52 | 631.02 | 642.95 | 635.6 | Upgrade
|
| EBIT | 992.67 | 1,422 | 4,486 | 3,651 | 522.54 | 643.23 | Upgrade
|
| EBIT Margin | 10.36% | 16.11% | 34.40% | 36.55% | 9.93% | 10.78% | Upgrade
|
| Effective Tax Rate | 17.94% | 16.75% | 14.92% | 15.42% | 81.60% | 13.21% | Upgrade
|
| Revenue as Reported | 9,582 | 8,824 | 13,039 | 9,987 | 5,261 | 5,969 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.